May 11, 2021
First Quarter 2021 Record Revenue of Approximately $28.9 Million Representing 466% Growth over First Quarter 2020 Announced Plans to Launch Two New Diagnostic Tests – SARS-CoV-2 Neutralization Antibody Detection Test and Next Generation Sequencing Test BOULDER, Colo.–(BUSINESS WIRE)–$BDSX #patientsfirst—Biodesix, Inc. Read more…
